|
1
|
Ilkanizadeh S, Lau J, Huang M, Foster DJ,
Wong R, Frantz A, Wang S, Weiss WA and Persson AI: Glial
progenitors as targets for transformation in glioma. Adv Cancer
Res. 121:1–65. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang K, Sun X, Zhou X, Han L, Chen L, Shi
Z, Zhang A, Ye M, Wang Q, Liu C, et al: Long non-coding RNA HOTAIR
promotes glioblastoma cell cycle progression in an EZH2 dependent
manner. Oncotarget. 6:537–546. 2015.PubMed/NCBI
|
|
3
|
Sadetzki S, Zach L, Chetrit A, Nass D,
Hoffmann C, Ram Z, Zaaroor M, Umansky F, Rappaport ZH, Cohen A, et
al: Epidemiology of gliomas in Israel: A nationwide study.
Neuroepidemiology. 31:264–269. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al: Radiotherapy plus concomitant and adjuvant temozolomide
for glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee JH, Jung TY, Jung S, Kim IY, Jang WY,
Moon KS and Jeong EH: Performance status during and after
radiotherapy plus concomitant and adjuvant temozolomide in elderly
patients with glioblastoma multiforme. J Clin Neurosci. 20:503–508.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liang BC, Thornton AF Jr, Sandler HM and
Greenberg HS: Malignant astrocytomas: Focal tumor recurrence after
focal external beam radiation therapy. J Neurosurg. 75:559–563.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Héricé C, Khalil R, Moftah M, Boraud T,
Guthrie M and Garenne A: Decision making under uncertainty in a
spiking neural network model of the basal ganglia. J Integra
Neurosci. 15:515–538. 2016. View Article : Google Scholar
|
|
8
|
Zhu P, Wang Y, Wu J, Huang G, Liu B, Ye B,
Du Y, Gao G, Tian Y, He L and Fan Z: LncBRM initiates YAP1
signalling activation to drive self-renewal of liver cancer stem
cells. Nat Commun. 7:136082016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu B, Ye B, Yang L, Zhu X, Huang G, Zhu
P, Du Y, Wu J, Qin X, Chen R, et al: Long noncoding RNA lncKdm2b is
required for ILC3 maintenance by initiation of Zfp292 expression.
Nat Immunol. 18:499–508. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Smolle MA, Leithner A, Posch F, Szkandera
J, Liegl-Atzwanger B and Pichler M: MicroRNAs in different
histologies of soft tissue sarcoma: A comprehensive review. Int J
Mol Sci. 18:pii: E1960. 2017. View Article : Google Scholar
|
|
11
|
He L, He X, Lim LP, de Stanchina E, Xuan
Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D, et al: A microRNA
component of the p53 tumour suppressor network. Nature.
447:1130–1134. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Townley-Tilson WH, Callis TE and Wang D:
MicroRNAs 1, 133, and 206: Critical factors of skeletal and cardiac
muscle development, function, and disease. Int J Biochem Cell Biol.
42:1252–1255. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang J, Xu D, Li N, Li Y, He Y, Hu X, Lyu
L and He L: Downregulation of microRNA-31 inhibits proliferation
and induces apoptosis by targeting HIF1AN in human keloid.
Oncotarget. 8:74623–74634. 2017.PubMed/NCBI
|
|
14
|
Zhou C, Jiang CQ, Zong Z, Lin JC and Lao
LF: miR-146a promotes growth of osteosarcoma cells by targeting
ZNRF3/GSK-3β/β-catenin signaling pathway. Oncotarget.
8:74276–74286. 2017.PubMed/NCBI
|
|
15
|
Qu Y, Liu H, Lv X, Liu Y, Wang X, Zhang M,
Zhang X, Li Y, Lou Q, Li S and Li H: MicroRNA-16-5p overexpression
suppresses proliferation and invasion as well as triggers apoptosis
by targeting VEGFA expression in breast carcinoma. Oncotarget.
8:72400–72410. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou X, Wu W, Zeng A, Nie E, Jin X, Yu T,
Zhi T, Jiang K, Wang Y, Zhang J and You Y: MicroRNA-141-3p promotes
glioma cell growth and temozolomide resistance by directly
targeting p53. Oncotarget. 8:71080–71094. 2017.PubMed/NCBI
|
|
17
|
Zhao Y and Wang Y and Wang Y: Up-regulated
miR-500a enhances hepatocarcinoma metastasis by repressing PTEN
expression. Biosci Rep. 37:2017. View Article : Google Scholar
|
|
18
|
Esposti Degli D, Aushev VN, Lee E, Cros
MP, Zhu J, Herceg Z, Chen J and Hernandez-Vargas H: miR-500a-5p
regulates oxidative stress response genes in breast cancer and
predicts cancer survival. Sci Rep. 7:159662017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guo Y, Chen L, Sun C and Yu C:
MicroRNA-500a promotes migration and invasion in hepatocellular
carcinoma by activating the Wnt/β-catenin signaling pathway. Biomed
Pharmacother. 91:13–20. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Allen M, Bjerke M, Edlund H, Nelander S
and Westermark B: Origin of the U87MG glioma cell line: Good news
and bad news. Sci Transl Med. 8:354re32016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gaur AB, Holbeck SL, Colburn NH and Israel
MA: Downregulation of Pdcd4 by mir-21 facilitates glioblastoma
proliferation in vivo. Neuro Oncol. 13:580–590. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xu YF, Hannafon BN, Zhao YD, Postier RG
and Ding WQ: Plasma exosome miR-196a and miR-1246 are potential
indicators of localized pancreatic cancer. Oncotarget.
8:77028–77040. 2017.PubMed/NCBI
|
|
24
|
Rizzo S, Cangemi A, Galvano A, Fanale D,
Buscemi S, Ciaccio M, Russo A, Castorina S and Bazan V: Analysis of
miRNA expression profile induced by short term starvation in breast
cancer cells treated with doxorubicin. Oncotarget. 8:71924–71932.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li W, Yang W, Liu Y, Chen S, Chin S, Qi X,
Zhao Y, Liu H, Wang J, Mei X, et al: MicroRNA-378 enhances
inhibitory effect of curcumin on glioblastoma. Oncotarget.
8:73938–73946. 2017.PubMed/NCBI
|
|
26
|
Zhu W, Qian J, Ma L, Ma P, Yang F and Shu
Y: MiR-346 suppresses cell proliferation through SMYD3 dependent
approach in hepatocellular carcinoma. Oncotarget. 8:65218–65229.
2017.PubMed/NCBI
|
|
27
|
Liu N, Zhang L, Wang Z, Cheng Y, Zhang P,
Wang X, Wen W, Yang H, Liu H, Jin W, et al: MicroRNA-101 inhibits
proliferation, migration and invasion of human glioblastoma by
targeting SOX9. Oncotarget. 8:19244–19254. 2017.PubMed/NCBI
|
|
28
|
Jiang C, Long J, Liu B, Xu M, Wang W, Xie
X, Wang X and Kuang M: miR-500a-3p promotes cancer stem cells
properties via STAT3 pathway in human hepatocellular carcinoma. J
Exp Clin Cancer Res. 36:992017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mei Z, He Y, Feng J, Shi J, Du Y, Qian L,
Huang Q and Jie Z: MicroRNA-141 promotes the proliferation of
non-small cell lung cancer cells by regulating expression of PHLPP1
and PHLPP2. FEBS Lett. 588:3055–3061. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Baykara O, Tansarikaya M, Bulut P,
Demirkaya A and Buyru N: CHD5 is a potential tumor suppressor in
non small cell lung cancer (NSCLC). Gene. 618:65–68. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang L, He S, Tu Y, Ji P, Zong J, Zhang J,
Feng F, Zhao J, Gao G and Zhang Y: Downregulation of chromatin
remodeling factor CHD5 is associated with a poor prognosis in human
glioma. J Clin Neurosci. 20:958–963. 2013. View Article : Google Scholar : PubMed/NCBI
|
